- The Kaynes share price fell 20.15% after investors sold off the stock due to concerns about its working capital adequacy and profit decline.
Current Setup and Live Chart
KAYNEs is the ticker for the NSE-listed stock known as Kaynes Technology Ltd. The company is an Indian EMS compounder stock which is now trading within the scope of the market reaction to its earnings report, which was viewed in many quarters as disappointing.
Despite the earnings report showing rising revenues, the numbers have drawn great angst among traders and investors after guidance misses and disappointing balance sheet metrics. The earnings report showed a 37% YoY increase in its 9 months revenue, with a 55% YoY growth in its EBITDA. The management of the company also indicated that it had a relatively robust order book of around ~₹9,072 crore, equivalent to 1.5 years of revenue visibility. It also indicated that its FY2028 revenue target of $1bn is still valid.
However, the markets were not particularly pleased with the totality of the report, as the company reported a profit decline of 21.5% YoY to 91.2 crore rupees in the face of rising employee and input costs. This resulted in a selloff that compounded the stock’s woes. Following the 20% intraday drop, the stock has lost more than half of its value from September 2025 to date. The steep intraday drop comes on the back of concerns regarding the margins and the cash-generating capacity of the company’s business model. Several broker downgrades have followed the earnings release.
JM Financial flagged the company’s negative operating cash flow of 600 crore rupees in FY2026, which it warns could cause the company’s debt profile to rise as it would then need to borrow to fund its planned 8,000 crore rupees capex spend until FY2028.
JP Morgan and Nuvama also downgraded the stock. JP Morgan downgraded the stock’s Rating from Overweight to Neutral, cutting its Kaynes share price target to 4,000 rupees. Nuvama downgraded the stock to Hold, and slashed its Kaynes price target from 5,500 to 3,500 after the company missed Nuvama’s profit estimates by 13%.
CLSA maintained its Outperform rating with a Kaynes share price target of 4,200 rupees, but noted that the results did not meet expectations.
Kaynes Share Price: Macro Drivers
1. Earnings Scrutiny vs Order Book
The company indicated it has a strong order book, providing it with demand visibility. Investors typically reward large order books. However, the profits and guidance miss now place the onus of proof on Kaynes Technology to show investors that it can translate this demand visibility into margins and cash generation.
2) OSAT Facility: A key Execution Factor
A subsidiary of the company built and commissioned a 3,300 crore rupees Outsourced Semiconductor Assembly and Test (OSAT) complex in March 2026. This facility is expected to deliver advanced packaging and testing of Intelligent Power Modules (IPMs) for the automotive industry. The OSAT facility is expected to be a key upside and execution factor for Kaynes Technology. The company indicates that operational and support agreements have been signed; a key positive that is execution-heavy.
3) Working Capital Adequacy
A major driver of the market’s negative reaction to the earnings result is the continued cash burn, as JM Financial noted. The situation could reduce the company’s working capital, leaving it reliant on debt financing to meet its capex projections. The reaction of investors with such a heavy selloff is indicative of their willingness to react adversely to any signs of working capital stress and cash flow weakness, despite revenue growth.
Price Catalysts in the Near Term
Broker guidance follow-through: The markets will watch for any revisions to the recent downgrades by JPMorgan and Nuvama, as well as for further ratings adjustments by other brokers. This is a key short-term catalyst for price action.
OSAT ramp headlines: Any headlines or updates around the OSAT ramp’s milestones, and the impact this will have on existing margins/cash flow.
Working capital status: Managerial commentary or updates around the working capital situation, including adjustments of the capex projections to match the current near-term cash position realities.
Kaynes Share Price: Forecast Scenarios
Base case: price to remain in a volatile, choppy consolidation. The stock will remain sensitive to headlines around the downgrades until there is more confidence around the earnings quality and cash position.
Bull case: Expect a sharp rebound if there are new headlines around the OSAT ramp, which should boost order conversion and improve the company’s cash position. Also, working capital discipline and any updates that convince the market that the drop-off in profits was a transient event will be supportive of the Kaynes share price.
Bear case: A further selloff could be in the works if the company’s cash flow and working capital position come under skeptical scrutiny. Also, any new information that prompts further broker downgrades could prompt more selling.
Kaynes Share Price: Technical Outlook
The 3326 support and prior low of 28 January 2026 is now being tested by the latest price decline, which also coincides with the end-point of the measured move from the double top of 23 April and 11 May 2026. If this support level is breached, a further decline towards the 4 June 2024 low at 2829 cannot be ruled out. Below this level, additional support comes in at 2423, the double bottom lows of 15 April and 8 May 2026.
On the flip side, a bounce on the 3326 support level makes a case for a retest of the double top’s neckline at 3910, the former low of 11 February and 7 April 2025. Above this level, additional resistance targets come in at 4530 (double top highs), and 5472 if the former is uncapped by recovering price action.
